• Become A Member
  • Gift Membership
  • Gift Membership
Scroll.in Logo
  • Gift Membership
  • Sign In
  • Become A Member
  • Home
  • Common Ground
  • The Latest
  • Members-Only
  • Video
  • Eco India
  • The Reel
  • Magazine
  • Trending
    Trending
    • Five rejoinders: What Ramachandra Guha gets wrong about Rahul Gandhi

      Five rejoinders: What Ramachandra Guha gets wrong about Rahul Gandhi

      Scroll
    • Why India is not able to fully use the solar power it generates

      Why India is not able to fully use the solar power it generates

      Vaishnavi Rathore
    • In this speculative memoir, an academic writes about chronic pain and liminal spaces she exists in

      In this speculative memoir, an academic writes about chronic pain and liminal spaces she exists in

      Shahd Alshammari
    • Ramachandra Guha: How the Gandhi family has helped Modi consolidate power

      Ramachandra Guha: How the Gandhi family has helped Modi consolidate power

      Ramachandra Guha
    • The Muslim maestro at the heart of a Hindu temple tradition

      The Muslim maestro at the heart of a Hindu temple tradition

      Malini Nair
    • Jeff Bezos says poetry without rhyming is easy – but it’s not that simple

      Jeff Bezos says poetry without rhyming is easy – but it’s not that simple

      Bronwyn Lea, The Conversation
    • An ‘indigenous’ Assamese woman was pushed into Bangladesh. A year later, she is still stuck there

      An ‘indigenous’ Assamese woman was pushed into Bangladesh. A year later, she is still stuck there

      Rokibuz Zaman
    • Hindusthan Records: How the shepherd boy playing a flute brought music into Indian homes

      Hindusthan Records: How the shepherd boy playing a flute brought music into Indian homes

      Subha Das Mollick
    • ‘Making procedures visible helps clarify how historical interpretations are formed’: Romila Thapar

      ‘Making procedures visible helps clarify how historical interpretations are formed’: Romila Thapar

      Abdullah Khan
    • Honey, they shrunk the Mohanlal phenomenon into ‘Lalettan’

      Honey, they shrunk the Mohanlal phenomenon into ‘Lalettan’

      Harish Pullanoor
    • High Court issues notice to Punjab on plea against meat ban in Amritsar’s walled city

      High Court issues notice to Punjab on plea against meat ban in Amritsar’s walled city

      Scroll Staff
    • Why Delhi University’s four-year undergraduate programme has left students in panic

      Why Delhi University’s four-year undergraduate programme has left students in panic

      Johanna Deeksha
    We Need Your Help
    Scroll has produced award-winning journalism despite threats, falling ad revenues and rising costs. Support our work. Become a member today.
  • More
    More
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Health
    • Education
    • Climate and Environment
    Newsletters
    • The Daily Brief
    • Now Watching By The Reel
    Read on the Go
    Get updates
    Please Don't Look Away
    AI is hollowing out independent media, stealing our readership and revenue. Only you can stop this bleeding. Support our work. Join Scroll today!
  • Newsletters

US FDA

  • US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    Tabassum Barnagarwala
    · Apr 04, 2023 · 03:00 pm
  • Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Scroll Staff
    · Nov 05, 2021 · 06:29 pm
  • Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Scroll Staff
    · Sep 20, 2021 · 06:11 pm
  • Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Scroll Staff
    · Jun 11, 2021 · 11:51 am
  • Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Scroll Staff
    · Dec 08, 2020 · 09:31 pm
  • US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    Scroll Staff
    · Nov 22, 2020 · 08:58 am
  • Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Scroll Staff
    · Nov 18, 2020 · 01:36 pm
  • Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Scroll Staff
    · Jun 15, 2020 · 10:55 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 06:35 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 05:35 pm
  • India’s largest drugmaker gets a warning letter from US FDA

    India’s largest drugmaker gets a warning letter from US FDA

    Scroll Staff
    · Dec 20, 2015 · 02:13 pm